Cargando…

STEAP1–4 (Six-Transmembrane Epithelial Antigen of the Prostate 1–4) and Their Clinical Implications for Prostate Cancer

SIMPLE SUMMARY: Despite recent therapeutic advances in the treatment of prostate cancer, metastatic castration-resistant prostate cancer continues to cause significant morbidity and mortality. New research into highly expressed proteins in metastatic castration-resistant prostate cancer shows that S...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Michael, Evans, Latese, Bizzaro, Candice L., Quaglia, Fabio, Verrillo, Cecilia E., Li, Li, Stieglmaier, Julia, Schiewer, Matthew J., Languino, Lucia R., Kelly, William K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406800/ https://www.ncbi.nlm.nih.gov/pubmed/36011027 http://dx.doi.org/10.3390/cancers14164034

Ejemplares similares

Mechanism of stepwise electron transfer in six-transmembrane epithelial antigen of the prostate (STEAP) 1 and 2
por: Chen, Kehan, et al.
Publicado: (2023)

Cryo-electron microscopy structure and potential enzymatic function of human six-transmembrane epithelial antigen of the prostate 1 (STEAP1)
por: Oosterheert, Wout, et al.
Publicado: (2020)

Expression of STEAP1 and STEAP1B in prostate cell lines, and the putative regulation of STEAP1 by post-transcriptional and post-translational mechanisms
por: Gomes, Inês M., et al.
Publicado: (2014)

STEAP1 expression in prostate cancer and its regulation by androgens
por: Gomes, Inês, et al.
Publicado: (2010)

Potential of six-transmembrane epithelial antigen of the prostate 4 as a prognostic marker for colorectal cancer
por: Fang, Ze-Xuan, et al.
Publicado: (2022)

Clinical significance of STEAP1 extracellular vesicles in prostate cancer
por: Khanna, Karan, et al.
Publicado: (2021)

Six‐transmembrane epithelial antigen of prostate 3 (STEAP3) is a potential prognostic biomarker in clear cell renal cell carcinoma that correlates with M2 macrophage infiltration and epithelial–mesenchymal
por: Wei, Haotian, et al.
Publicado: (2023)

Six-Transmembrane Epithelial Antigen of Prostate 4: An Indicator of Prognosis and Tumor Immunity in Hepatocellular Carcinoma
por: Ju, Mi Ha, et al.
Publicado: (2023)

Targeting advanced prostate cancer with STEAP1 chimeric antigen receptor T cell and tumor-localized IL-12 immunotherapy
por: Bhatia, Vipul, et al.
Publicado: (2023)

Immune responses of six-transmembrane epithelial antigen of the prostate 4 functions as a novel biomarker in gastric cancer
por: Fang, Ze-Xuan, et al.
Publicado: (2023)

Expression and prognostic analyses of the significance of STEAP1 and STEAP2 in lung cancer
por: Liu, Tianshu, et al.
Publicado: (2022)

STEAP1 Knockdown Decreases the Sensitivity of Prostate Cancer Cells to Paclitaxel, Docetaxel and Cabazitaxel
por: Rocha, Sandra M., et al.
Publicado: (2023)

Promoter Demethylation Upregulates STEAP1 Gene Expression in Human Prostate Cancer: In Vitro and In Silico Analysis
por: Rocha, Sandra M., et al.
Publicado: (2021)

STEAP2 Knockdown Reduces the Invasive Potential of Prostate Cancer Cells
por: Burnell, Stephanie E. A., et al.
Publicado: (2018)

Six-Transmembrane Epithelial Antigen of Prostate 3 Promotes Hepatic Insulin Resistance and Steatosis
por: Ding, Ting, et al.
Publicado: (2022)

Specific Six-Transmembrane Epithelial Antigen of the Prostate 1 Capture with Gellan Gum Microspheres: Design, Optimization and Integration
por: Batista-Silva, João, et al.
Publicado: (2023)

EIF4E regulates STEAP1 expression in peritoneal metastasis
por: Jiang, Jun-nan, et al.
Publicado: (2020)

Murine double minute 2 aggravates adipose tissue dysfunction through ubiquitin-mediated six-transmembrane epithelial antigen of prostate 4 degradation
por: Zhao, Wei, et al.
Publicado: (2022)

Six-Transmembrane Epithelial Antigen of Prostate 3 Predicts Poor Prognosis and Promotes Glioblastoma Growth and Invasion
por: Han, Mingzhi, et al.
Publicado: (2018)

Regulatory Roles of Six-Transmembrane Epithelial Antigen of the Prostate Family Members in the Occurrence and Development of Malignant Tumors
por: Chen, Wen-Jia, et al.
Publicado: (2021)

Six-transmembrane epithelial antigen of the prostate 1 accelerates cell proliferation by targeting c-Myc in liver cancer cells
por: Iijima, Kazutaka, et al.
Publicado: (2021)

Targeting STEAP1 as an anticancer strategy
por: Nakamura, Hajime, et al.
Publicado: (2023)

Six-transmembrane epithelial antigen of the prostate and enhancer of zeste homolog 2 as immunotherapeutic targets for lung cancer
por: Hayashi, Satoshi, et al.
Publicado: (2011)

STEAP1 regulation and its influence modulating the response of LNCaP prostate cancer cells to bicalutamide, enzalutamide and apalutamide
por: Rocha, Sandra M., et al.
Publicado: (2023)

Role of Transmembrane 4 L Six Family 1 in the Development and Progression of Cancer
por: Fu, Fangmei, et al.
Publicado: (2020)

The expression of STEAP4 in peripheral blood predicts the outcome of septic patients
por: Jiang, Haiyan, et al.
Publicado: (2021)

Development of STEAP1 targeting chimeric antigen receptor for adoptive cell therapy against cancer
por: Jin, Yixin, et al.
Publicado: (2022)

High expression of six-transmembrane epithelial antigen of prostate 3 promotes the migration and invasion and predicts unfavorable prognosis in glioma
por: Deng, Langmei, et al.
Publicado: (2023)

lncRNA STEAP3-AS1 Modulates Cell Cycle Progression via Affecting CDKN1C Expression through STEAP3 in Colon Cancer
por: Na, Heya, et al.
Publicado: (2020)

Fusion Protein Vaccine Based on Ag85B and STEAP1 Induces a Protective Immune Response against Prostate Cancer
por: Guo, Linpei, et al.
Publicado: (2021)

Enhanced Stability of Detergent-Free Human Native STEAP1 Protein from Neoplastic Prostate Cancer Cells upon an Innovative Isolation Procedure
por: Barroca-Ferreira, Jorge, et al.
Publicado: (2021)

Six‐Transmembrane Epithelial Antigen of the Prostate 3 Deficiency in Hepatocytes Protects the Liver Against Ischemia‐Reperfusion Injury by Suppressing Transforming Growth Factor‐β‐Activated Kinase 1
por: Guo, Wen‐Zhi, et al.
Publicado: (2019)

Utilisation of the STEAP protein family in a diagnostic setting may provide a more comprehensive prognosis of prostate cancer
por: Burnell, Stephanie E. A., et al.
Publicado: (2019)

A Molecular Docking Study of Human STEAP2 for the Discovery of New Potential Anti-Prostate Cancer Chemotherapeutic Candidates
por: Ongaba, Timothy, et al.
Publicado: (2022)

Steap4 attenuates high glucose and S100B-induced effects in mesangial cells
por: Chuang, Chao-Tang, et al.
Publicado: (2015)

Cryo-EM structures of human STEAP4 reveal mechanism of iron(III) reduction
por: Oosterheert, Wout, et al.
Publicado: (2018)

STEAP4 expression in CNS resident cells promotes Th17 cell-induced autoimmune encephalomyelitis
por: Zhao, Junjie, et al.
Publicado: (2021)

TGM4: an immunogenic prostate-restricted antigen
por: Lopez-Bujanda, Zoila A, et al.
Publicado: (2021)

Treatment with metformin prevents myocardial ischemia–reperfusion injury via STEAP4 signaling pathway
por: Luo, Ting, et al.
Publicado: (2019)

STEAP1 Regulates Tumorigenesis and Chemoresistance During Peritoneal Metastasis of Gastric Cancer
por: Wu, Yuan-Yu, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_m4jfajbqqpguath1peasmq57eh